LABCORP HOLDINGS INC. — Director's Dealing 2018

Feb 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2018-02-12

Reporting Person: EISENBERG GLENN A (Chief Financial Officer, EVP)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-12	Common Stock	S	6300	$167.157	Disposed	15931	Direct
2018-02-12	Common Stock	S	1600	$167.7775	Disposed	14331	Direct
2018-02-12	Common Stock	S	500	$168.614	Disposed	13831	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-12	Non-qualified Stock Options	$168.49	A	9100	Acquired	2028-02-11	Common Stock (9100)	Direct
2018-02-12	Restricted Stock Unit	$	A	2340	Acquired		Common Stock (2340)	Direct

Footnotes

F1: The price of $167.1570 per share represents a weighted average of sales prices ranging from $166.58 to $167.53 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security
holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F2: The price of $167.7775 per share represents a weighted average of sales prices ranging from $167.59 to $168.58 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security
holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F3: The price of $168.6140 per share represents a weighted average of sales prices ranging from $168.59 to $168.68 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security
holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F4: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.

F5: The option vests in three equal installments beginning on the date reflected in this column.

F6: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F7: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2019.

F8: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.